Grant: Alliance Grants
McGill University
$114,975.00
Plasmonic PCR for point of care diagnostics
FY 2024-25
Summary
The polymerase chain reaction (PCR) is used in thousands of laboratories worldwide every day to perform specific amplification of nucleic acid material, including DNA. In the past few years PCR has emerged as the tool of choice for the medical diagnosis of a wide range of infections, including Tuberculosis, Hepatitis, Dengue, Malaria, Chlamydia and most recently for the SARS-Cov-2 virus that is the cause of COVID-19. In contrast to old methods, PCR can provide a very accurate and direct measurement of the DNA or RNA that come from pathogens and that are present in samples taken from a patient. However, commercial PCR machines are typically large and power-hungry devices that can take over an hour to deliver results. If results could be delivered rapidly, while the patient is still present, we could revolutionise infection control and patient treatment. This has motivated us to rethink the way that a PCR machine should work. Most commercial PCR machines use thermoelectric heating and cooling blocks to ramp the temperature of the PCR mixture up and down over 30-40 cycles. In our system we heat the PCR mixture directly from within. We do this by incorporating gold nanorods into the mixture then shine the light from an infrared laser into the PCR tube. This greatly increases heating efficiency AND reduces the thermal mass of the system, and so also makes cooling faster. As a result we have shown that PCR results can be delivered in as little as 7 minutes. This technology is patent protected and although the first user-ready prototype has recently been completed, there remain significant research questions that must be solved in order to extract the full benefits of this technology. This includes the addition of a method to extract the nucleic acid from the patient sample, improvements in the cooling rate, simultaneous detection of multiple pathogens and techniques to improve heating uniformity. We anticipate that this research will lead to further intellectual property, academic publications and will contribute to the training of several highly qualified personnel in an interdisciplinary setting that requires knowledge of photonics, biology, physics and medicine.
Program
Alliance Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
576169-2022
Name nom
Kirk, Andrew AK
Department département
Electrical and Computer Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
114975
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Plasmonic PCR for point of care diagnostics
Keywords
aptamers; dna; fluorescence; microfluidics; molecular diagnostics; optoelectronics; plasmonics; polymerase chain reaction; rna; thermal management
Application summary
The polymerase chain reaction (PCR) is used in thousands of laboratories worldwide every day to perform specific amplification of nucleic acid material, including DNA. In the past few years PCR has emerged as the tool of choice for the medical diagnosis of a wide range of infections, including Tuberculosis, Hepatitis, Dengue, Malaria, Chlamydia and most recently for the SARS-Cov-2 virus that is the cause of COVID-19. In contrast to old methods, PCR can provide a very accurate and direct measurement of the DNA or RNA that come from pathogens and that are present in samples taken from a patient. However, commercial PCR machines are typically large and power-hungry devices that can take over an hour to deliver results. If results could be delivered rapidly, while the patient is still present, we could revolutionise infection control and patient treatment. This has motivated us to rethink the way that a PCR machine should work. Most commercial PCR machines use thermoelectric heating and cooling blocks to ramp the temperature of the PCR mixture up and down over 30-40 cycles. In our system we heat the PCR mixture directly from within. We do this by incorporating gold nanorods into the mixture then shine the light from an infrared laser into the PCR tube. This greatly increases heating efficiency AND reduces the thermal mass of the system, and so also makes cooling faster. As a result we have shown that PCR results can be delivered in as little as 7 minutes. This technology is patent protected and although the first user-ready prototype has recently been completed, there remain significant research questions that must be solved in order to extract the full benefits of this technology. This includes the addition of a method to extract the nucleic acid from the patient sample, improvements in the cooling rate, simultaneous detection of multiple pathogens and techniques to improve heating uniformity. We anticipate that this research will lead to further intellectual property, academic publications and will contribute to the training of several highly qualified personnel in an interdisciplinary setting that requires knowledge of photonics, biology, physics and medicine.